Bioventus (BVS) Shares Outstanding (2021 - 2026)
Bioventus' (BVS) quarterly Shares Outstanding (Entity) came in at $67.6 million in Q1 2026, up 2.13% YoY from $66.2 million in Q1 2025, and up 0.81% on a QoQ basis from $67.1 million in Q4 2025.
Bioventus (BVS) Shares Outstanding (2021 - 2026) Analysis & Trends
Bioventus (BVS) has 6 years of Shares Outstanding (Entity) data on file, last reported at $67.6 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 2.13% year-over-year to $67.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.6 million (up 2.13% YoY) and the FY2025 annual result came in at $67.1 million, up 2.04% from the prior year.
- Shares Outstanding (Entity) climbed to $67.6 million in Q1 2026, from $67.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $67.6 million in Q1 2026 to a low of $61.4 million in Q2 2022.
- A 5-year average of $64.3 million and a median of $63.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 50.32% — and 2023, when it increased 1.86%.
- Tracing BVS's Shares Outstanding (Entity) over 5 years: stood at $62.1 million in 2022, then gained by 1.94% to $63.3 million in 2023, then grew by 3.94% to $65.8 million in 2024, then climbed by 2.04% to $67.1 million in 2025, then increased by 0.81% to $67.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $67.6 million (Q1 2026), $67.1 million (Q4 2025), and $67.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn | 67.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 67.87 Mn |
| Mar 28, 2026 | 67.30 Mn |
| Dec 31, 2025 | 66.62 Mn |
| Sep 27, 2025 | 66.92 Mn |
| Jun 28, 2025 | 66.50 Mn |
| Mar 29, 2025 | 66.01 Mn |
| Dec 31, 2024 | 64.55 Mn |
| Sep 28, 2024 | 65.26 Mn |
| Jun 29, 2024 | 64.06 Mn |
| Mar 30, 2024 | 63.38 Mn |
| Dec 31, 2023 | 62.65 Mn |
| Sep 30, 2023 | 62.82 Mn |
| Jul 1, 2023 | 62.55 Mn |
| Apr 1, 2023 | 62.12 Mn |
| Dec 31, 2022 | 61.39 Mn |
| Oct 1, 2022 | 61.67 Mn |
| Jul 2, 2022 | 61.48 Mn |
| Apr 2, 2022 | 60.48 Mn |
| Dec 31, 2021 | 45.47 Mn |
| Oct 2, 2021 | 41.84 Mn |